John M. Hoffmann

Array ( [id] => 6110293 [patent_doc_number] => 20110189181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Use of agents derived from CEACAM1 for the treatment of inflammatory diseases' [patent_app_type] => utility [patent_app_number] => 12/806002 [patent_app_country] => US [patent_app_date] => 2010-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8621 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189181.pdf [firstpage_image] =>[orig_patent_app_number] => 12806002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134964 [patent_doc_number] => 20110008789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'METHODS AND MATERIALS FOR TREATING INFLAMMATORY CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/833773 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 21189 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008789.pdf [firstpage_image] =>[orig_patent_app_number] => 12833773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650890 [patent_doc_number] => 20110300159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'Sulfonated Sclerostin, antibodies, epitopes and methods for identification and use therefor' [patent_app_type] => utility [patent_app_number] => 12/802447 [patent_app_country] => US [patent_app_date] => 2010-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10143 [patent_no_of_claims] => 130 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300159.pdf [firstpage_image] =>[orig_patent_app_number] => 12802447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6613649 [patent_doc_number] => 20100310469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS' [patent_app_type] => utility [patent_app_number] => 12/475957 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15827 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310469.pdf [firstpage_image] =>[orig_patent_app_number] => 12475957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134460 [patent_doc_number] => 20110008362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'ANTI-GLUTEN EGG YOLK ANTIBODIES FOR THE TREATMENT OF CELIAC DISEASE' [patent_app_type] => utility [patent_app_number] => 12/779622 [patent_app_country] => US [patent_app_date] => 2010-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6404 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008362.pdf [firstpage_image] =>[orig_patent_app_number] => 12779622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8189732 [patent_doc_number] => 20120117670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'HUMANIZED AXL ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/320060 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 78 [patent_figures_cnt] => 78 [patent_no_of_words] => 47759 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20120117670.pdf [firstpage_image] =>[orig_patent_app_number] => 13320060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234663 [patent_doc_number] => 20100266490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'Metalloproteinase Binding Proteins' [patent_app_type] => utility [patent_app_number] => 12/776195 [patent_app_country] => US [patent_app_date] => 2010-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 57454 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266490.pdf [firstpage_image] =>[orig_patent_app_number] => 12776195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7488846 [patent_doc_number] => 20110236973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'Centrosome proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/799795 [patent_app_country] => US [patent_app_date] => 2010-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 26029 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236973.pdf [firstpage_image] =>[orig_patent_app_number] => 12799795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742300 [patent_doc_number] => 20120020978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'ANTIBODIES AGAINST FATTY ACID SYNTHASE' [patent_app_type] => utility [patent_app_number] => 13/258666 [patent_app_country] => US [patent_app_date] => 2010-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13691 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20120020978.pdf [firstpage_image] =>[orig_patent_app_number] => 13258666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149339 [patent_doc_number] => 20110020934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'Fusion Partner for Production of Monoclonal Rabbit Antibodies' [patent_app_type] => utility [patent_app_number] => 12/755212 [patent_app_country] => US [patent_app_date] => 2010-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7214 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020934.pdf [firstpage_image] =>[orig_patent_app_number] => 12755212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320620 [patent_doc_number] => 20100196390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'AGONIST ANTI-TRKB MONOCLONAL ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/697983 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 43335 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196390.pdf [firstpage_image] =>[orig_patent_app_number] => 12697983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6531928 [patent_doc_number] => 20100221317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'DYNAMIN MEDIATED DISEASES AND ASSOCIATED METHODS AND PRODUCTS' [patent_app_type] => utility [patent_app_number] => 12/693858 [patent_app_country] => US [patent_app_date] => 2010-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 36116 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221317.pdf [firstpage_image] =>[orig_patent_app_number] => 12693858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6433772 [patent_doc_number] => 20100278820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'REAGENTS THAT BIND CCX-CKR2' [patent_app_type] => utility [patent_app_number] => 12/691576 [patent_app_country] => US [patent_app_date] => 2010-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15088 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278820.pdf [firstpage_image] =>[orig_patent_app_number] => 12691576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7535369 [patent_doc_number] => 08048995 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-01 [patent_title] => 'Human skeletal muscle-specific ubiquitin-conjugating enzyme' [patent_app_type] => utility [patent_app_number] => 12/689917 [patent_app_country] => US [patent_app_date] => 2010-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19690 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/048/08048995.pdf [firstpage_image] =>[orig_patent_app_number] => 12689917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8232373 [patent_doc_number] => 08197814 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-12 [patent_title] => 'Method for treating the Th2-mediated disease' [patent_app_type] => utility [patent_app_number] => 12/684651 [patent_app_country] => US [patent_app_date] => 2010-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 26655 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/197/08197814.pdf [firstpage_image] =>[orig_patent_app_number] => 12684651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228887 [patent_doc_number] => 20100183625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Treatment of Mucositis with Kallikrein Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/683094 [patent_app_country] => US [patent_app_date] => 2010-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 43724 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183625.pdf [firstpage_image] =>[orig_patent_app_number] => 12683094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6236215 [patent_doc_number] => 20100267618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'Methods for treating congestive heart failure' [patent_app_type] => utility [patent_app_number] => 12/655361 [patent_app_country] => US [patent_app_date] => 2009-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14443 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267618.pdf [firstpage_image] =>[orig_patent_app_number] => 12655361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7500398 [patent_doc_number] => 20110262929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'ANTI-HS6ST2 ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/998988 [patent_app_country] => US [patent_app_date] => 2009-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 27890 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262929.pdf [firstpage_image] =>[orig_patent_app_number] => 12998988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289829 [patent_doc_number] => 20100158896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'ANTIBODY THAT SPECIFICALLY BINDS HYALURONAN SYNTHASE' [patent_app_type] => utility [patent_app_number] => 12/638803 [patent_app_country] => US [patent_app_date] => 2009-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 52483 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158896.pdf [firstpage_image] =>[orig_patent_app_number] => 12638803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4463839 [patent_doc_number] => 07935502 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-03 [patent_title] => 'Hepatocyte growth factor (HGF) binding proteins' [patent_app_type] => utility [patent_app_number] => 12/632758 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 34260 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/935/07935502.pdf [firstpage_image] =>[orig_patent_app_number] => 12632758 [rel_patent_id] =>[rel_patent_doc_number] =>)